The discovery and development of an efficient synthesis route to axinitib is reported. The first-generation route researched by Pfizer, implemented two Pd-catalyzed coupling reactions as key steps. In this work, the development of Heck-type and C-S coupling reactions catalyzed by CuI is briefly described, using an economic and practical protocol. Aspects of route, such as selecting ligands, solvent and other conditions are discussed in detail to obtain the optimal conditions. The scale up experiment was carried out to provide more than 300 g active pharmaceutical ingredients (API) of axitinib in Form XLI which was produced with 99.9 % purity in 39 % yield. In short, we provide a new choice of axitinib synthesis route, through two copper-catalyzed coupling reactions with good yield.